* 中国疫苗生产商--康希诺H股6185.HK周五早盘一度弹升6.1%，其A股688185.SS至多涨3.6%，生产基地通过马来西亚药监局PIC/S GMP符合性检查。
* 恒生生物科技指数.HSBIO盘中升3%。
* 康希诺公告称，公司ACYW135群脑膜炎球菌多糖结合疫苗（CRM197载体）、13价肺炎球菌多糖结合疫苗（CRM197/破伤风类毒素）的生产基地通过了马来西亚药监局PIC/SGMP符合性检查，并于近日获得NPRA颁发的GMP证书。
本次通过PIC/SGMP认证，标志着公司的生产和质量管理体系符合PIC/SGMP的标准，将有助于推进MCV4、PCV13i在马来西亚及其他PIC/S成员国药品注册上市的工作。。
* 年初迄今，康希诺港股累计跌3%，同期A股涨超一成。（完）
更多股市简讯请点选CN-CMN-HOT
(发稿 崔珠珠；审校 杨淑祯)
((zhuzhu.cui@thomsonreuters.com; +86-21-20830048;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.